Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock
Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn about a recent article by Jia Li et al, published in Frontiers in Pharmacology, adding:
“Could a blood test warn doctors hours before a sepsis patient takes a dangerous turn?
A 2026 review in Frontiers in Pharmacology by Li and colleagues explores that hope.
Sepsis is the body’s runaway reaction to infection.
When it goes far enough, blood pressure crashes and organs fail.
In some intensive care units, more than 4 in 10 of these patients die.
The authors look at tiny ‘warning signals’ in the blood that rise before the usual symptoms.
In one cited study of 142 patients, a signal called IL-6 correctly flagged the high-risk patients about 80 percent of the time.
Most signals still need testing before doctors can fully trust them.”
Title: Early biomarkers for predicting sepsis-induced shock: insights from inflammatory pathways and immune response
Authors: Jia Li, Qiufang Zhao, Haiyun Gao, Hongjun Wang, Cong Guo, Xiaoling Feng

Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 24, 2026, 00:41Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders